JP2022539342A5 - - Google Patents
Info
- Publication number
- JP2022539342A5 JP2022539342A5 JP2021576883A JP2021576883A JP2022539342A5 JP 2022539342 A5 JP2022539342 A5 JP 2022539342A5 JP 2021576883 A JP2021576883 A JP 2021576883A JP 2021576883 A JP2021576883 A JP 2021576883A JP 2022539342 A5 JP2022539342 A5 JP 2022539342A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- compound
- approximately
- solid crystalline
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025001914A JP2025069143A (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962865826P | 2019-06-24 | 2019-06-24 | |
| US62/865,826 | 2019-06-24 | ||
| PCT/US2020/039163 WO2020263847A1 (en) | 2019-06-24 | 2020-06-23 | Solid forms of tert-butyl (s)-2-((2s,3r) -1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing them |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025001914A Division JP2025069143A (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539342A JP2022539342A (ja) | 2022-09-08 |
| JP2022539342A5 true JP2022539342A5 (enExample) | 2023-06-30 |
| JP7617043B2 JP7617043B2 (ja) | 2025-01-17 |
Family
ID=74060350
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576883A Active JP7617043B2 (ja) | 2019-06-24 | 2020-06-23 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
| JP2025001914A Pending JP2025069143A (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025001914A Pending JP2025069143A (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220267341A1 (enExample) |
| EP (1) | EP3986399A4 (enExample) |
| JP (2) | JP7617043B2 (enExample) |
| CN (1) | CN114364380A (enExample) |
| AU (1) | AU2020304001B2 (enExample) |
| BR (1) | BR112021026380A2 (enExample) |
| CA (1) | CA3144600A1 (enExample) |
| IL (1) | IL289198A (enExample) |
| MA (1) | MA56550A (enExample) |
| MX (2) | MX2022000069A (enExample) |
| WO (1) | WO2020263847A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4484431A3 (en) * | 2019-06-24 | 2025-03-26 | Naurex Inc. | Processes and intermediates for producing diazaspiro lactam compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0323204D0 (en) * | 2003-10-03 | 2003-11-05 | Novartis Ag | Organic compounds |
| ES2416354T3 (es) * | 2005-06-21 | 2013-07-31 | Ajinomoto Co., Inc. | Cristal de derivado de fenilalanina, método de producción del mismo y uso del mismo |
| BRPI0918868B8 (pt) * | 2008-09-18 | 2021-05-25 | Naurex Inc | compostos moduladores do receptor de nmda e composições compreendendo os mesmos |
| US9758525B2 (en) * | 2013-01-29 | 2017-09-12 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| PE20151416A1 (es) * | 2013-01-29 | 2015-10-10 | Naurex Inc | Moduladores de receptores nmda de espiro-lactama y sus usos |
| DK3436463T3 (da) * | 2016-03-28 | 2021-08-30 | Takeda Pharmaceuticals Co | Krystalline former af 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-on hemi-hydrat |
| PE20190174A1 (es) | 2016-05-19 | 2019-02-01 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos |
| EP4484431A3 (en) * | 2019-06-24 | 2025-03-26 | Naurex Inc. | Processes and intermediates for producing diazaspiro lactam compounds |
-
2020
- 2020-06-23 US US17/621,907 patent/US20220267341A1/en active Pending
- 2020-06-23 EP EP20832010.1A patent/EP3986399A4/en active Pending
- 2020-06-23 CN CN202080059974.0A patent/CN114364380A/zh active Pending
- 2020-06-23 BR BR112021026380A patent/BR112021026380A2/pt unknown
- 2020-06-23 JP JP2021576883A patent/JP7617043B2/ja active Active
- 2020-06-23 MA MA056550A patent/MA56550A/fr unknown
- 2020-06-23 CA CA3144600A patent/CA3144600A1/en active Pending
- 2020-06-23 MX MX2022000069A patent/MX2022000069A/es unknown
- 2020-06-23 AU AU2020304001A patent/AU2020304001B2/en active Active
- 2020-06-23 WO PCT/US2020/039163 patent/WO2020263847A1/en not_active Ceased
-
2021
- 2021-12-21 IL IL289198A patent/IL289198A/en unknown
-
2022
- 2022-01-03 MX MX2025002579A patent/MX2025002579A/es unknown
-
2025
- 2025-01-06 JP JP2025001914A patent/JP2025069143A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023528450A5 (enExample) | ||
| JP2023511105A5 (enExample) | ||
| JP2006511588A5 (enExample) | ||
| JP2012521994A5 (enExample) | ||
| JP2017518355A5 (enExample) | ||
| JP2013541592A5 (enExample) | ||
| TW200916454A (en) | Process for controlled crystal size in 1,2-substituted 3,4-dioxo-1-cyclobutene compounds | |
| JP2024095561A5 (enExample) | ||
| JP2022539342A5 (enExample) | ||
| CN107698574B (zh) | 一种高纯度阿瑞匹坦的精制制备工艺 | |
| NO324731B1 (no) | Karbocyklisk hemisulfat, anvendelse og fremstilling derav, samt farmasoytisk formulering og dikarboksylatsalt, gutarsalt og monosulfat, benzoat eller salicylatsalt | |
| JP2023517729A5 (enExample) | ||
| CN1443178A (zh) | (r)-n-[5-甲基-8-(4-甲基哌嗪-1-基)-1,2,3,4-四氢-2-萘基]-4-吗啉代苯甲酰胺的新形态 | |
| AU2026200097A1 (en) | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof | |
| RU2019128576A (ru) | Сокристаллы замещенных глициновых соединений и их применение | |
| CN110590606B (zh) | 用于制备嘧啶基环戊烷化合物的方法 | |
| JP4268055B2 (ja) | 精製されたラソフォキシフェンおよび再結晶によりラセミ体ラソフォキシフェンを精製するための方法 | |
| JP2025069143A (ja) | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 | |
| CN103864627B (zh) | 福莫特罗手性中间体的拆分方法 | |
| JP2022525169A5 (enExample) | ||
| CN103025705B (zh) | 4-甲基苯甲酸4-[2-二甲基胺基-1-(1-羟基环己基)乙基]苯酯盐酸盐的多晶型物、制备方法及其应用 | |
| TW201124139A (en) | Solid forms of 4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)piperazin-1-yl]methyl}-n, n-diethylbenzamide, compositions thereof, and uses therewith | |
| JP2023522331A5 (enExample) | ||
| CN102030689A (zh) | 一种富马酸伊布利特的精制方法 | |
| CN112724081B (zh) | 一种异烟肼的制备方法 |